IT IS AGREED:Research Agreement • March 31st, 2005 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Connecticut
Contract Type FiledMarch 31st, 2005 Company Industry Jurisdiction
EXHIBIT 10.26 AMENDMENT NO. 1 OF RESEARCH AGREEMENT The Agreement amendments stated herein are made by and between Antigenics, L.L.C., hereinafter referred to as Sponsor and the University of Connecticut Health Center, hereinafter referred to as UCHC....Research Agreement • March 31st, 2005 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
Contract Type FiledMarch 31st, 2005 Company Industry
Exhibit 10.28 February 10, 2005 Leonard P. Paplauskas Associate Vice President for Research Administration University of Connecticut Health Center Center for Science and Technology Commercialization 263 Farmington Avenue Farmington, CT 06030 RE:...Antigenics Inc /De/ • March 31st, 2005 • Biological products, (no disgnostic substances)
Company FiledMarch 31st, 2005 IndustryThis letter is in reference to that certain Research Agreement by and between University of Connecticut Health Center ("UCHC") and Antigenics Inc., a Delaware corporation ("Antigenics Inc.")(each a "Party" and collectively the "Parties") dated February 28, 1998 ("Agreement"), as amended by Amendment No. 1 Research Agreement dated April 19, 2002, further amended by Amendment Agreement dated March 18, 2003, and further amended by Amendment No. 2 to Research Agreement dated December 30, 2003 (each singly an "Amendment", collectively the "Agreement"). In accordance with the provisions of Section 5.0 of the Agreement, Antigenics Inc. hereby agrees to pay UCHC an additional one-time payment in the sum of One Hundred Thirty-Five Thousand dollars ($135,000) for additional costs associated with activities to be performed under the Agreement in 2005.